A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus

Inactivated viral vaccines have long been used in humans for diseases of global health threat (e.g., poliomyelitis and pandemic and seasonal influenza) and the technology of inactivation has more recently been used for emerging diseases such as West Nile, Chikungunya, Ross River, SARS and especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Libia Milena, Sumathy, K., Sahastrabuddhe, Sushant, Excler, Jean-Louis, Kochhar, Sonali, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197579/
https://www.ncbi.nlm.nih.gov/pubmed/35715351
http://dx.doi.org/10.1016/j.vaccine.2022.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197579/
https://www.ncbi.nlm.nih.gov/pubmed/35715351
http://dx.doi.org/10.1016/j.vaccine.2022.06.006

Ejemplares similares